Its potential as a therapeutic target is further supported by interventions such as quercetin, which has been shown to ameliorate depression-related symptoms in breast cancer models through multi-faceted mechanisms that include the suppression of PTGS2 [44]. Here, PTGS2 is linked to depressive symptom measurement.